Oracle, Shares

Oracle Shares Face Sustained Headwinds Amid Strategic Challenges

Published on 02/25/2026 at 09:22 | Redaktion boerse-global.de

Oracle's stock falls amid soaring AI capex, a $50B funding plan, class-action lawsuits, and uncertainty around the 'Stargate' joint venture with OpenAI.

Oracle Shares Face Sustained Headwinds Amid Strategic Challenges Illustration mit AI erstellt übermittelt durch boerse-global.de
Oracle Shares Face Sustained Headwinds Amid Strategic Challenges Illustration mit AI erstellt übermittelt durch boerse-global.de

Oracle Corporation finds itself navigating a complex landscape of operational, financial, and legal pressures. Investor sentiment remains cautious as the company contends with uncertainty surrounding a major artificial intelligence initiative, soaring capital expenditure, and emerging legal challenges. The coming weeks will be critical for management to provide clarity and restore confidence.

Legal Proceedings Add to Investor Concerns

Beyond strategic and financial hurdles, Oracle is confronting legal scrutiny. Several law firms are advancing class-action lawsuits alleging misleading statements. One such case, Barrows v. Oracle Corporation in the District of Delaware, pertains to share purchases made between June 12, 2025, and December 16, 2025.

The core allegation is that Oracle portrayed its AI infrastructure strategy in a manner that obscured the disproportionate relationship between massive increases in capital spending and near-term revenue growth. The deadline for lead plaintiff motions is set for April 6, 2026, marking a key date in this legal front.

Funding a Costly AI and Cloud Expansion

A significant factor behind the stock's revaluation since late 2025 is the market's assessment of Oracle's aggressive push into AI and cloud infrastructure. The scale of required investment came into sharp focus with the release of fiscal Q2 2026 results on December 10, 2025. The company reported quarterly capital expenditures of $12 billion, which drove its free cash flow down to negative $10 billion.

Furthermore, management substantially raised its investment forecast for the full 2026 fiscal year. Capital spending is now projected to be approximately $15 billion higher than expectations following Q1.

To fund this ambitious plan, Oracle announced on February 1, 2026, its intention to raise $45 to $50 billion gross in the 2026 calendar year through a combination of debt and equity. These funds are earmarked for expanding cloud capacity to serve major clients, including AMD, Meta, Nvidia, OpenAI, TikTok, and xAI. The market's reaction to this financial burden is evident in the share price, which has declined 25.56% year-to-date to €124.32.

Should investors sell immediately? Or is it worth buying Oracle?

"Stargate" Joint Venture Stirs Fresh Uncertainty

Recent discussions were triggered by reports that the "Stargate" joint venture, involving partners such as OpenAI and SoftBank, may have stalled due to ongoing disagreements over the project's structure. This development is particularly sensitive for Oracle, as the venture is tightly linked to its AI ambitions and associated future revenue streams.

Additional pressure stems from the funding outlook for OpenAI. Reports suggesting that Nvidia might commit $30 billion in a funding round, rather than the $100 billion previously anticipated by some market observers, have heightened nerves. This is crucial context given that Oracle and OpenAI entered into a $300 billion deal in the fall of 2025. Any uncertainty regarding OpenAI's ability to finance its commitments directly impacts Oracle's own planning.

All Eyes on the Upcoming Quarterly Report

The next major catalyst for the stock arrives on March 9, 2026, with the fiscal Q3 2026 earnings report. Consensus estimates project earnings per share of $1.70, representing year-over-year growth of 15.65%, and revenue of $16.89 billion, an increase of 19.54%. Investors will focus intently on management commentary regarding remaining performance obligations, which stood at $523 billion in Q2, the status of the "Stargate" project, and most importantly, the forward path for capital investment.

Ad

Oracle Stock: New Analysis - 25 February

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLE | boerse | 68610311 |